Expression of mRNA for 5-HT2 receptors and proteins related to inactivation of 5-HT in mouse osteoblasts

Journal of Pharmacological Sciences

Volumn 109, Issue 2, 2009, Pages 319-323

  Hirai, Takao ^a   Tokumo, Kohji ^a   Tsuchiya, Daijyu ^a   Nishio, Hiroaki ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

5 HT transporter (5 HTT); 5 HT2 receptor; Osteoblast

Indexed keywords

MESSENGER RNA; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN 2 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ANAPLASTIC CARCINOMA; ANIMAL; CELL CULTURE; GENETICS; METABOLISM;

ANAPLASIA; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; MICE; OSTEOBLASTS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN, 5-HT2; RNA, MESSENGER; SEROTONIN;

EID: 65449118015     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08243SC     Document Type: Article

References (14)

1. Warden SJ, Bliziotes MM, Wiren KM, Eshleman AJ, Turner CH. Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Mol Cell Endocrinol. 2005;242:1-9.
2. Bliziotes MM, Eshleman AJ, Zhang XW, Wiren KM. Neurotransmitter action in osteoblasts: Expression of a functional system for serotonin receptor activation and reuptake. Bone. 2001;29:477-486.
3. Bliziotes MM, Eshleman A, Burt-Pichat B, Zhang XW, Hashimoto J, Wiren K, et al. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone. 2006;39:1313-1321.
4. Gustafsson BI, Westbroek I, Waarsing JH, Waldum H, Solligard E, Brunsvik A, et al. Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats. J Cell Biochem. 2006;97:1283-1291.
5. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem. 2006;98: 139-151.
6. Bonnet N, Bernard P, Beaupied H, Bizot JC, Trovero F, Courteix D, et al. Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol. 2007;221:111-118.
7. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167:188-194. (Pubitemid 46148067)
8. Warden SJ, Robling AG, Sanders MS, Bliziotes MM, Turner CH. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinol. 2005;146:685-693.
9. Fujita T, Fukuyama R, Izumo N, Hirai T, Meguro T, Nakamuta H, et al. Transactivation of core binding factor alpha1 as a basic mechanism to trigger parathyroid hormone-induced osteo- genesis. Jpn J Pharmacol. 2001;86:405-416. (Pubitemid 32888263)
10. Hirai T, Taniura H, Goto Y, Ogura M, Sng JC, Yoneda Y. Stimulation of ubiquitin-proteasome pathway through the expression of amidohydrolase for N-terminal asparagine (Ntan1) in cultured rat hippocampal neurons exposed to static magnetism. J Neurochem. 2006;96:1519-1530.
11. Tokumo K, Tamura N, Hirai T, Nishio H. Effects of (Z)-3- hexenol, a major component of green odor, on anxiety-related behavior of the mouse in an elevated plus-maze test and biogenic amines and their metabolites in the brain. Behav Brain Res. 2006;166:247-252.
12. Hirai T, Yoneda Y. Functional alterations in immature cultured rat hippocampal neurons after sustained exposure to static magnetic fields. J Neurosci Res. 2006;75:230-240.
13. Westbroek I, van der Plas A, de Rooij KE, Klein-Nulend J, Nijweide PJ. Expression of serotonin receptors in bone. J Biol Chem. 2001;276:28961-28968.
14. Collet C, Schiltz C, Geoffroy V, Maroteaux L, Launay JM, de Vernejoul MC. The serotonin 5-HT2b receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J. 2008;22:418-427.